Sudarshan Chem. Q1 FY27 Results (NSE: SUDARSCHEM)

· Analysis by Alpha Inflection

Signal: Margin expansion

The read

The quarter marks the first consolidated margin inflection after seven consecutive quarters of contraction: EBITDA margin recovered to 10.5% from an implied 8.7% YoY and EBITDA grew 27.3% despite only 5.4% revenue growth, but the thesis still depends on sustaining Pigments profitability while reversing the Others segment's ₹9.5 crore loss and reducing the standalone-versus-consolidated earnings gap.

Sudarshan Chem. Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹2,642.1 Cr5.4%-5.3%
EBIT₹184.7 Cr54.9%
Net profit₹97.3 Cr106.1%
EPS₹12.3105.0%
EBIT margin10.5%

P&L walk

Revenue was ₹2642.1 crore, up 5.4% YoY but down 5.3% QoQ; gross margin expanded to approximately 53.7% from 49.4% YoY, EBITDA margin rose to 10.5% from an implied 8.7%, and PAT attributable to owners increased 106.1% to ₹97.3 crore, supported by operating improvement and lower tax intensity despite ₹36.1 crore of integration and restructuring costs.

Segments

Pigments drove the consolidated recovery with revenue of ₹2604.4 crore, up 6.0% YoY, and EBITDA of ₹268.8 crore, up 39.9%, while Others deteriorated from ₹0.2 crore EBITDA profit to a ₹9.5 crore loss on revenue of ₹37.7 crore.

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.